OGEN - ORAGENICS INC
0.8999
0.011 1.267%
Share volume: 208,673
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.89
0.01
0.01%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 11-13-2024 | 03-14-2025 | 05-09-2025 | 08-08-2025 | 11-07-2025 | |
| Assets | ||||||
| Total Assets | 5.204 M | 1.473 M | 3.869 M | 2.140 M | 12.706 M | |
| Current Assets | 4.113 M | 1.473 M | 3.869 M | 2.140 M | 12.706 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 3.144 M | 864.840 K | 3.421 M | 1.974 M | 11.404 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 1.091 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 5.204 M | 1.473 M | 3.869 M | 2.140 M | 12.706 M | |
| Total liabilities | 2.127 M | 1.684 M | 3.731 M | 4.267 M | 2.874 M | |
| Total current liabilities | 2.127 M | 1.684 M | 3.731 M | 4.267 M | 2.874 M | |
| Accounts Payable | 1.607 M | 1.356 M | 1.177 M | 1.267 M | 2.479 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.485 M | -211.885 K | 137.688 K | -2.128 M | 9.831 M | |
| Common stock | 214.922 M | 216.574 M | 219.141 M | 219.147 M | 234.173 M | |
| Retained earnings | -213.437 M | -216.786 M | -219.003 M | -221.275 M | -224.342 M |